Sermorelin

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) corresponding to the first 29 amino acids of human GHRH. It has been studied for its effects on growth hormone secretion.

Research has examined Sermorelin primarily in relation to growth hormone secretion, the growth hormone/IGF-1 axis, and growth-related conditions.

Sermorelin acts through the GHRH receptor pathway, stimulating the pituitary gland to release growth hormone.

Growth hormone signaling can influence downstream production of insulin-like growth factor-1 (IGF-1). Research involving Sermorelin and GHRH(1-29) has examined changes in both growth hormone and IGF-1.

Yes. Sermorelin and GHRH(1-29) have been investigated in human clinical research, including studies involving growth hormone secretion and growth-related conditions.

Where applicable, independent laboratory documentation may provide information about product identity, purity, and other analytical characteristics of a tested batch. Analytical results apply only to the specific sample or batch identified in the applicable laboratory documentation.